NEWS CORNER

MAR

19 - 21

Lisbon, Portugal

Bioprocessing Summit Europe  Conference Talk

MAR

25 - 27

Vienna, Austria

Bio-Europe Spring  Spotlight Session

MAR

26 - 28

Boston, USA

Gene Therapy for Rare Disorders  Exhibitor

APR/MAY

29 - 02

Washington, DC, USA

ASGCT Annual Meeting  Exhibitor

JUN

03 - 06

Philadelphia, USA

Bio International Convention  Exhibitor

GTCA – GENE THERAPY CENTER AUSTRIA

We are your innovative partner for high-quality gene therapy solutions, bringing your product into phase III and to the market!
As a one-stop-shop, our well-established Gene Therapy platform offers vector optimization, process development and GMP manufacturing of your product.

ONE MISSION.
Our highly engaged GTCA teams dedicate their skills to enable global supply of high-quality gene therapy products for our patients. Beyond our own corporate boundaries, we offer our services to external partners. 30+ years’ experience in late stage development and commercialization expertise in the vaccines and recombinant biologics business, make us the ideal CMO/CDMO partner to bring your gene therapy product into phase III and to the market.

ONE PLATFORM.
Our proprietary, suspension-based platform process is applicable to all AAVs and ready for commercial manufacturing. Driven by our spirit of innovation and guided by years of experience, we seek to improve our technology portfolio day by day. Our quality-by-design approach allows us to be one step ahead by having quality imprinted into our process from the very beginning. This strategy is completed by our robust and mature quality management system and our established relationship with FDA and EMA.

ONE LOCATION.
Takeda’s Gene Therapy Center Austria offers extensive and scalable AAV process development and manufacturing capabilities. Having all in one place, we ensure seamless transfer from preclinical pilot scale to manufacturing, accompanied by a broad in-house analytical portfolio. As CMO/CDMO we are covering all steps from vector to cGMP manufacturing for clinical and commercial supply, all in one location – at our Gene Therapy Campus near Vienna/Austria.

INTERESTED TO BECOME A PARTNER?
Get in touch via GTCA@takeda.com